Dostarlimab

• Target :

  PD-1/PD-L1

• Related Pathways :

  Cell Cycle/Checkpoint|||Apoptosis|||Immunology/Inflammation

• Purity :

  0.9892

• Bioactivity :

  Dostarlimab (TSR-042) is a programmed cell death protein 1 (PD-1) receptor immune checkpoint inhibitor that blocks interactions with PD-L1 and PD-L2, used in the study of endometrial cancer.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2022215-59-2